Selective IKK2 inhibitor IMD0354 disrupts NF-κB signaling to suppress corneal inflammation and angiogenesis. [electronic resource]
Producer: 20191024Description: 267-285 p. digitalISSN:- 1573-7209
- Animals
- Animals, Genetically Modified
- Benzamides -- pharmacology
- Cornea -- metabolism
- Corneal Neovascularization -- drug therapy
- Eye Proteins -- antagonists & inhibitors
- Human Umbilical Vein Endothelial Cells
- Humans
- I-kappa B Kinase -- antagonists & inhibitors
- Keratitis -- drug therapy
- Male
- NF-kappa B -- genetics
- Rats
- Rats, Wistar
- Signal Transduction -- drug effects
- Zebrafish
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.